Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ryan Maynard Insider Profile
4 Followers
Ryan Maynard, EVP & CFO at Rigel, holds 0.00 shares in Rigel (Ticker: RIGL), holds 0.00 shares in Iovance Biotherapeutics (Ticker: IOVA).
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+62.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Ryan Maynard does not currently own shares as a corporate insider.
A breakdown of Ryan Maynard's holdings
Insider Roles
Roles that Ryan Maynard holds in companies
Most Profitable Insider Trade
The most profitable trade made by Ryan Maynard
Ryan Maynard's Trading History
Rigel
Nov 07, 2017
EVP & CFO
Uninformative Sell
390.00K
$0.00
Iovance Biotherapeutics
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Ryan Maynard's performance on stock
You May Also Like
Ryan Maynard insider profile FAQ
What is the percentage of profitable transactions made by Ryan Maynard?
The percentage of profitable transactions made by Ryan Maynard is 100%.
What is the average return per transaction made by Ryan Maynard?
The average return per transaction made by Ryan Maynard is 62.90%.
What stocks does Ryan Maynard hold?
Ryan Maynard holds: RIGL, IOVA stocks.
What was Ryan Maynard’s latest transaction?
Ryan Maynard latest transaction was an Uninformative Sell of $390.00K.
What was Ryan Maynard's most profitable transaction?
Ryan Maynard’s most profitable transaction was an Informative Sell of RIGL stock on September 11, 2012. The return on the trade was 65.20%.
What is Ryan Maynard's role in Rigel?
Ryan Maynard's role in Rigel is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.